Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at TD Cowen in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a $19.00 price target on the stock. TD Cowen’s target price would indicate a potential upside of 43.80% from the stock’s previous close.
Other equities research analysts have also issued reports about the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Surgery Partners in a research report on Friday, August 21st. Raymond James Financial set a $18.00 price target on Surgery Partners in a report on Tuesday, August 11th. JPMorgan Chase & Co. increased their price target on Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday. Royal Bank Of Canada dropped their price objective on Surgery Partners from $20.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday, August 11th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $18.00 price objective on shares of Surgery Partners in a research report on Tuesday, August 11th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.00.
Check Out Our Latest Research Report on Surgery Partners
Surgery Partners Stock Performance
Surgery Partners (NASDAQ:SGRY – Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company had revenue of $848.90 million for the quarter, compared to analyst estimates of $830.03 million. During the same quarter last year, the business earned $0.17 earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. As a group, research analysts anticipate that Surgery Partners will post 0.25 EPS for the current year.
Insider Activity
In related news, Director Teresa DeLuca bought 10,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was acquired at an average price of $14.35 per share, with a total value of $143,500.00. Following the completion of the purchase, the director directly owned 66,843 shares of the company’s stock, valued at approximately $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Surgery Partners
Several institutional investors have recently bought and sold shares of SGRY. PNC Financial Services Group Inc. raised its position in shares of Surgery Partners by 239.6% in the first quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock valued at $35,000 after buying an additional 2,051 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new stake in Surgery Partners during the 2nd quarter valued at about $38,000. Fifth Third Bancorp raised its holdings in Surgery Partners by 5,324.0% in the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after acquiring an additional 3,993 shares during the last quarter. Alpine Global Management LLC purchased a new position in Surgery Partners in the 4th quarter worth approximately $175,000. Finally, Empowered Funds LLC acquired a new position in shares of Surgery Partners during the 2nd quarter worth approximately $216,000.
Surgery Partners Company Profile
Surgery Partners, Inc (NASDAQ: SGRY) is a healthcare services company that owns and operates a network of ambulatory surgery centers and surgical hospitals in the United States. The company works with physicians and health systems to provide outpatient and same-day surgical care in settings outside traditional hospital facilities.
Its services cover a range of specialties, including orthopedics, pain management, gastroenterology, ophthalmology, gynecology, urology and other procedural areas.
Featured Stories
- Five stocks we like better than Surgery Partners
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
- Braze Beat Expectations—Now 2 SaaS Peers Are in Focus
- 3 Zero-Fee ETFs Worth More Than Their Cost
- 3 Nimble Free Cash Flow Names With Light Assets
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
